Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Myasthenia Gravis (MG) Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Drug Treatment 1.4.3 Rapid Immunotherapies 1.4.4 Others 1.5 Market by Application 1.5.1 Global Myasthenia Gravis (MG) Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospitals and Clinics 1.5.3 Diagnostic Centers 1.5.4 Academic and Research Organizations 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Myasthenia Gravis (MG) Treatment Market Perspective (2015-2026) 2.2 Myasthenia Gravis (MG) Treatment Growth Trends by Regions 2.2.1 Myasthenia Gravis (MG) Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Myasthenia Gravis (MG) Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Myasthenia Gravis (MG) Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Myasthenia Gravis (MG) Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Myasthenia Gravis (MG) Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Myasthenia Gravis (MG) Treatment Players by Market Size 3.1.1 Global Top Myasthenia Gravis (MG) Treatment Players by Revenue (2015-2020) 3.1.2 Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Myasthenia Gravis (MG) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Myasthenia Gravis (MG) Treatment Market Concentration Ratio 3.2.1 Global Myasthenia Gravis (MG) Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis (MG) Treatment Revenue in 2019 3.3 Myasthenia Gravis (MG) Treatment Key Players Head office and Area Served 3.4 Key Players Myasthenia Gravis (MG) Treatment Product Solution and Service 3.5 Date of Enter into Myasthenia Gravis (MG) Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Myasthenia Gravis (MG) Treatment Historic Market Size by Type (2015-2020) 4.2 Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Type (2021-2026) 5 Myasthenia Gravis (MG) Treatment Breakdown Data by Application (2015-2026) 5.1 Global Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) 5.2 Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Myasthenia Gravis (MG) Treatment Market Size (2015-2020) 6.2 Myasthenia Gravis (MG) Treatment Key Players in North America (2019-2020) 6.3 North America Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) 6.4 North America Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Myasthenia Gravis (MG) Treatment Market Size (2015-2020) 7.2 Myasthenia Gravis (MG) Treatment Key Players in Europe (2019-2020) 7.3 Europe Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) 7.4 Europe Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) 8 China 8.1 China Myasthenia Gravis (MG) Treatment Market Size (2015-2020) 8.2 Myasthenia Gravis (MG) Treatment Key Players in China (2019-2020) 8.3 China Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) 8.4 China Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Myasthenia Gravis (MG) Treatment Market Size (2015-2020) 9.2 Myasthenia Gravis (MG) Treatment Key Players in Japan (2019-2020) 9.3 Japan Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) 9.4 Japan Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Myasthenia Gravis (MG) Treatment Market Size (2015-2020) 10.2 Myasthenia Gravis (MG) Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) 11 India 11.1 India Myasthenia Gravis (MG) Treatment Market Size (2015-2020) 11.2 Myasthenia Gravis (MG) Treatment Key Players in India (2019-2020) 11.3 India Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) 11.4 India Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Myasthenia Gravis (MG) Treatment Market Size (2015-2020) 12.2 Myasthenia Gravis (MG) Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) 12.4 Central & South America Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Alexion Pharmaceutical 13.1.1 Alexion Pharmaceutical Company Details 13.1.2 Alexion Pharmaceutical Business Overview and Its Total Revenue 13.1.3 Alexion Pharmaceutical Myasthenia Gravis (MG) Treatment Introduction 13.1.4 Alexion Pharmaceutical Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020)) 13.1.5 Alexion Pharmaceutical Recent Development 13.2 Grifols 13.2.1 Grifols Company Details 13.2.2 Grifols Business Overview and Its Total Revenue 13.2.3 Grifols Myasthenia Gravis (MG) Treatment Introduction 13.2.4 Grifols Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) 13.2.5 Grifols Recent Development 13.3 Avadel Pharmaceuticals 13.3.1 Avadel Pharmaceuticals Company Details 13.3.2 Avadel Pharmaceuticals Business Overview and Its Total Revenue 13.3.3 Avadel Pharmaceuticals Myasthenia Gravis (MG) Treatment Introduction 13.3.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) 13.3.5 Avadel Pharmaceuticals Recent Development 13.4 Novartis 13.4.1 Novartis Company Details 13.4.2 Novartis Business Overview and Its Total Revenue 13.4.3 Novartis Myasthenia Gravis (MG) Treatment Introduction 13.4.4 Novartis Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) 13.4.5 Novartis Recent Development 13.5 Pfizer 13.5.1 Pfizer Company Details 13.5.2 Pfizer Business Overview and Its Total Revenue 13.5.3 Pfizer Myasthenia Gravis (MG) Treatment Introduction 13.5.4 Pfizer Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) 13.5.5 Pfizer Recent Development 13.6 AbbVie 13.6.1 AbbVie Company Details 13.6.2 AbbVie Business Overview and Its Total Revenue 13.6.3 AbbVie Myasthenia Gravis (MG) Treatment Introduction 13.6.4 AbbVie Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) 13.6.5 AbbVie Recent Development 13.7 F. Hoffmann-La Roche 13.7.1 F. Hoffmann-La Roche Company Details 13.7.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue 13.7.3 F. Hoffmann-La Roche Myasthenia Gravis (MG) Treatment Introduction 13.7.4 F. Hoffmann-La Roche Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) 13.7.5 F. Hoffmann-La Roche Recent Development 13.8 GlaxoSmithKline 13.8.1 GlaxoSmithKline Company Details 13.8.2 GlaxoSmithKline Business Overview and Its Total Revenue 13.8.3 GlaxoSmithKline Myasthenia Gravis (MG) Treatment Introduction 13.8.4 GlaxoSmithKline Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) 13.8.5 GlaxoSmithKline Recent Development 13.9 Bausch Health Companies 13.9.1 Bausch Health Companies Company Details 13.9.2 Bausch Health Companies Business Overview and Its Total Revenue 13.9.3 Bausch Health Companies Myasthenia Gravis (MG) Treatment Introduction 13.9.4 Bausch Health Companies Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) 13.9.5 Bausch Health Companies Recent Development 13.10 Shire 13.10.1 Shire Company Details 13.10.2 Shire Business Overview and Its Total Revenue 13.10.3 Shire Myasthenia Gravis (MG) Treatment Introduction 13.10.4 Shire Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) 13.10.5 Shire Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Myasthenia Gravis (MG) Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Myasthenia Gravis (MG) Treatment Revenue Table 3. Ranking of Global Top Myasthenia Gravis (MG) Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Drug Treatment Table 6. Key Players of Rapid Immunotherapies Table 7. Key Players of Others Table 8. Global Myasthenia Gravis (MG) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Myasthenia Gravis (MG) Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Myasthenia Gravis (MG) Treatment Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Myasthenia Gravis (MG) Treatment Market Share by Regions (2015-2020) Table 12. Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Myasthenia Gravis (MG) Treatment Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Myasthenia Gravis (MG) Treatment Market Growth Strategy Table 18. Main Points Interviewed from Key Myasthenia Gravis (MG) Treatment Players Table 19. Global Myasthenia Gravis (MG) Treatment Revenue by Players (2015-2020) (Million US$) Table 20. Global Myasthenia Gravis (MG) Treatment Market Share by Players (2015-2020) Table 21. Global Top Myasthenia Gravis (MG) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myasthenia Gravis (MG) Treatment as of 2019) Table 22. Global Myasthenia Gravis (MG) Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Myasthenia Gravis (MG) Treatment Product Solution and Service Table 25. Date of Enter into Myasthenia Gravis (MG) Treatment Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$) Table 28. Global Myasthenia Gravis (MG) Treatment Market Size Share by Type (2015-2020) Table 29. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Myasthenia Gravis (MG) Treatment Market Size Share by Application (2015-2020) Table 31. Global Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$) Table 32. Global Myasthenia Gravis (MG) Treatment Market Size Share by Application (2021-2026) Table 33. North America Key Players Myasthenia Gravis (MG) Treatment Revenue (2019-2020) (Million US$) Table 34. North America Key Players Myasthenia Gravis (MG) Treatment Market Share (2019-2020) Table 35. North America Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$) Table 36. North America Myasthenia Gravis (MG) Treatment Market Share by Type (2015-2020) Table 37. North America Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$) Table 38. North America Myasthenia Gravis (MG) Treatment Market Share by Application (2015-2020) Table 39. Europe Key Players Myasthenia Gravis (MG) Treatment Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Myasthenia Gravis (MG) Treatment Market Share (2019-2020) Table 41. Europe Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$) Table 42. Europe Myasthenia Gravis (MG) Treatment Market Share by Type (2015-2020) Table 43. Europe Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$) Table 44. Europe Myasthenia Gravis (MG) Treatment Market Share by Application (2015-2020) Table 45. China Key Players Myasthenia Gravis (MG) Treatment Revenue (2019-2020) (Million US$) Table 46. China Key Players Myasthenia Gravis (MG) Treatment Market Share (2019-2020) Table 47. China Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$) Table 48. China Myasthenia Gravis (MG) Treatment Market Share by Type (2015-2020) Table 49. China Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$) Table 50. China Myasthenia Gravis (MG) Treatment Market Share by Application (2015-2020) Table 51. Japan Key Players Myasthenia Gravis (MG) Treatment Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Myasthenia Gravis (MG) Treatment Market Share (2019-2020) Table 53. Japan Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$) Table 54. Japan Myasthenia Gravis (MG) Treatment Market Share by Type (2015-2020) Table 55. Japan Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$) Table 56. Japan Myasthenia Gravis (MG) Treatment Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Myasthenia Gravis (MG) Treatment Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Myasthenia Gravis (MG) Treatment Market Share (2019-2020) Table 59. Southeast Asia Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Myasthenia Gravis (MG) Treatment Market Share by Type (2015-2020) Table 61. Southeast Asia Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Myasthenia Gravis (MG) Treatment Market Share by Application (2015-2020) Table 63. India Key Players Myasthenia Gravis (MG) Treatment Revenue (2019-2020) (Million US$) Table 64. India Key Players Myasthenia Gravis (MG) Treatment Market Share (2019-2020) Table 65. India Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$) Table 66. India Myasthenia Gravis (MG) Treatment Market Share by Type (2015-2020) Table 67. India Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$) Table 68. India Myasthenia Gravis (MG) Treatment Market Share by Application (2015-2020) Table 69. Central & South America Key Players Myasthenia Gravis (MG) Treatment Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Myasthenia Gravis (MG) Treatment Market Share (2019-2020) Table 71. Central & South America Myasthenia Gravis (MG) Treatment Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Myasthenia Gravis (MG) Treatment Market Share by Type (2015-2020) Table 73. Central & South America Myasthenia Gravis (MG) Treatment Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Myasthenia Gravis (MG) Treatment Market Share by Application (2015-2020) Table 75. Alexion Pharmaceutical Company Details Table 76. Alexion Pharmaceutical Business Overview Table 77. Alexion Pharmaceutical Product Table 78. Alexion Pharmaceutical Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$) Table 79. Alexion Pharmaceutical Recent Development Table 80. Grifols Company Details Table 81. Grifols Business Overview Table 82. Grifols Product Table 83. Grifols Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$) Table 84. Grifols Recent Development Table 85. Avadel Pharmaceuticals Company Details Table 86. Avadel Pharmaceuticals Business Overview Table 87. Avadel Pharmaceuticals Product Table 88. Avadel Pharmaceuticals Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$) Table 89. Avadel Pharmaceuticals Recent Development Table 90. Novartis Company Details Table 91. Novartis Business Overview Table 92. Novartis Product Table 93. Novartis Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$) Table 94. Novartis Recent Development Table 95. Pfizer Company Details Table 96. Pfizer Business Overview Table 97. Pfizer Product Table 98. Pfizer Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$) Table 99. Pfizer Recent Development Table 100. AbbVie Company Details Table 101. AbbVie Business Overview Table 102. AbbVie Product Table 103. AbbVie Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$) Table 104. AbbVie Recent Development Table 105. F. Hoffmann-La Roche Company Details Table 106. F. Hoffmann-La Roche Business Overview Table 107. F. Hoffmann-La Roche Product Table 108. F. Hoffmann-La Roche Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$) Table 109. F. Hoffmann-La Roche Recent Development Table 110. GlaxoSmithKline Business Overview Table 111. GlaxoSmithKline Product Table 112. GlaxoSmithKline Company Details Table 113. GlaxoSmithKline Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$) Table 114. GlaxoSmithKline Recent Development Table 115. Bausch Health Companies Company Details Table 116. Bausch Health Companies Business Overview Table 117. Bausch Health Companies Product Table 118. Bausch Health Companies Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$) Table 119. Bausch Health Companies Recent Development Table 120. Shire Company Details Table 121. Shire Business Overview Table 122. Shire Product Table 123. Shire Revenue in Myasthenia Gravis (MG) Treatment Business (2015-2020) (Million US$) Table 124. Shire Recent Development Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global Myasthenia Gravis (MG) Treatment Market Share by Type: 2020 VS 2026 Figure 2. Drug Treatment Features Figure 3. Rapid Immunotherapies Features Figure 4. Others Features Figure 5. Global Myasthenia Gravis (MG) Treatment Market Share by Application: 2020 VS 2026 Figure 6. Hospitals and Clinics Case Studies Figure 7. Diagnostic Centers Case Studies Figure 8. Academic and Research Organizations Case Studies Figure 9. Myasthenia Gravis (MG) Treatment Report Years Considered Figure 10. Global Myasthenia Gravis (MG) Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Myasthenia Gravis (MG) Treatment Market Share by Regions: 2020 VS 2026 Figure 12. Global Myasthenia Gravis (MG) Treatment Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Myasthenia Gravis (MG) Treatment Market Share by Players in 2019 Figure 15. Global Top Myasthenia Gravis (MG) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myasthenia Gravis (MG) Treatment as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Myasthenia Gravis (MG) Treatment Revenue in 2019 Figure 17. North America Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Alexion Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Alexion Pharmaceutical Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020) Figure 26. Grifols Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Grifols Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020) Figure 28. Avadel Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020) Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Novartis Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020) Figure 32. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Pfizer Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020) Figure 34. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. AbbVie Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020) Figure 36. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. F. Hoffmann-La Roche Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020) Figure 38. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. GlaxoSmithKline Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020) Figure 40. Bausch Health Companies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Bausch Health Companies Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020) Figure 42. Shire Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Shire Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2015-2020) Figure 44. Bottom-up and Top-down Approaches for This Report Figure 45. Data Triangulation Figure 46. Key Executives Interviewed

Alexion Pharmaceutical Grifols Avadel Pharmaceuticals Novartis Pfizer AbbVie F. Hoffmann-La Roche GlaxoSmithKline Bausch Health Companies Shire